365. Strategics: How Olympus Innovation Ventures Is Building the Future of MedTech Innovation with Abigail Hunter-Syed

In this episode, Omar Khateeb speaks with Abby Hunter-Syed, Director at Olympus Innovation Ventures, about how corporate venture capital is accelerating MedTech innovation. Abby shares how they invest in early-stage healthcare startups across endoscopy, diagnostics, GI health, and digital health, and how corporate venture helps founders navigate clinical validation, regulatory approval, and commercialization. They also discuss how investors evaluate early-stage MedTech companies and the signals that indicate future success.Episode Breakdown: 00:00 Intro and Today’s Topic01:08 Meet Abby Hunter-Syed and Olympus Innovation Ventures02:16 Abby’s Non-Linear Career Path into Venture Capital04:00 Why MedTech Innovation Is Accelerating05:18 Device Interventions vs Lifelong Pharmaceuticals06:36 GLP-1 Drugs vs Bariatric Procedures16:07 Are New Strategic Buyers Changing MedTech Investing?17:51 Going Earlier vs Writing Bigger Checks in MedTech19:18 What Olympus Looks for in Startup Investments20:15 Why Transparency Matters Between Investors and Founders22:13 How Venture Firms Discover New MedTech Startups23:37 Corporate Venture Capital as a Service Explained24:34 The Hottest Innovation Areas in MedTech Right Now25:55 Why Colorectal Cancer Screening Needs Innovation26:30 Wearables and Preventive Healthcare Trends27:43 Full Body MRI and Preventive Cancer Screening30:16 New Consumer Health Technologies and At-Home Diagnostics32:33 Early Signals That Predict Startup Success34:33 Why Investors Hide Behind “Come Back When You Have Revenue”36:00 The Importance of Founder Conviction38:43 Why MedTech Struggles to Attract Talent and Capital40:43 The Real Challenges of Building MedTech Companies41:50 Regulatory and Reimbursement Barriers in Healthcare43:37 Paying Cash for Healthcare and New Consumer Models46:49 Advice for MedTech Founders48:27 Final Thoughts and Episode Wrap UpAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #corporateventure #healthtech #startupinvesting